Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Eurogin
 

May 30 - June 1, 2021

  • 
  • Scientific Information
    • Message from the Chairman of the Scientific Committee
    • Program Committee
    • Program Objectives
    • Key Features And Target Audience
    • Previous Congress Presidents
    • Previous Congresses
  • Program & CME
    • Online Program
    • Program Overview
    • Program Topics
    • HPV And Head & Neck Forum
  • Registration
    • Online Registration
    • Registration Information
  • Abstracts & Posters
    • Abstract Information
    • Abstract Submission
    • Abstract Topics
  • Sponsorship And Exhibition
    • Sponsorship Information
    • Sponsorship Brochure 2021
    • Sponsors and Exhibitors
    • Ethical Compliance
  • Congress Information
    • Contact us
    • newsletter
    • Legal Information
    • Picture Gallery 2019
  • Login

EUROGIN 2021 is going Virtual

Dear colleagues,

Our priority is to keep attendees, faculty and sponsors safe. Given the continuing uncertainties related to the Covid-19 pandemic, EUROGIN 2021 is going to be fully virtual this year.

This means EUROGIN’s unrivalled content will remain identical as planned for the face-to-face event. In fact, delegates will have access to a wider range of presentations, as it will be possible to navigate through different program streams at any time during the congress, and benefit from exclusive access to all presentations for 4 months after the conference.

We are also happy to welcome participants from around the world who would be unable to travel and will now have the opportunity to join for a full EUROGIN experience.

We look forward to welcoming you to EUROGIN 2021 on our virtual conference platform on May 30 - June 1.

Best wishes and keep safe,

The EUROGIN Organizing Committee

INTERACTIVE PROGRAM

Check out the program of the EUROGIN 2021 Congress

MORE INFORMATION
img-responsive

HPV and Head & Neck Forum

The EUROGIN HPV and Head & Neck Cancer Forum highlights recent advances and areas of active research in the field of HPV-related head and neck cancers. This year’s Forum features the emerging role of biomarkers in screening and management of HPV-related oropharyngeal cancer, updates from deintensification trials and other therapeutic innovations, and a dedicated session focusing on molecular & immunologic considerations.

MORE INFORMATION
img-responsive

Specialized Workshops

• CERVICAL CANCER SCREENING ORGANIZATION AROUND THE WORLD

• VULVOVAGINAL DISEASES COURSE

• COLPOSCOPY COURSE

• WORKSHOP FRANCOPHONE (in French)

HPV 2021 - Von der Wissenschaft zur Praxis

Deutschsprachig - Montag 31. Mai

MORE INFORMATION
img-responsive

REGISTRATION

Advance registration rate will be available until April 27, 2021.
Final rate will be available from April 28, 2021.

Register now
img-responsive
Registration Info
img-responsive

EUROGIN PRE-CONGRESS WEBINARS SERIES

HIGHLIGHTS ON HPV INFECTION & ASSOCIATED CANCER
FROM RESEARCH TO PRACTICE

MORE INFORMATION
img-responsive
Discover our next webinars
On-demand Webinars

Cervical cancer prevention: HPV Vaccine Impact and Safety

March 15

9:00 pm (Melbourne) - 11:00 am (Paris) - 10:00 am (London)

Julia Brotherton (Cancer Epidemiologist, Australia)

This webinar will provide a brief primer on the mountain of evidence now supporting both the safety and impact of HPV vaccines in population use, as an introduction to the latest data which will be presented at Eurogin 2021.
Register for free
Replay our past webinar
On-demand Webinars

Risk Adapted Triage for Cervical Screening

Jack Cuzick (Epidemiologist, UK)

There are no clear factors for deciding who to screen for cervix cancer, other than previous abnormalities and the results of an initial test. The initial test can be either cytology or HPV testing. As we are moving towards primary HPV testing the focus here will be on the risk of disease based on a primary HPV test, how this can be refined by doing different triage tests. These include HPV genotyping, cytology, methylation, and p16 in a liquid-based sample. Algorithms for how best to employ these (depending on what is routinely available) will be discussed.
▶ Replay

Sponsorship

For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]

Sponsors & Exhibitors List

2019 Exhibitors List
img-responsive
Exhibiting Opportunities
img-responsive

Ethical Med Tech

The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conferene vetting system on all assessment criteria:

  • Scientific Programme
  • Geographic Location
  • Conference Venue
  • Hospitality
  • Registration Packages
  • Communication

PHOTO GALLERY2019

OPENING CEREMONY

SCIENTIFIC SESSIONS

REGISTRATION

EXHIBITION

ABOUT EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

ETHICAL COMPLIANCE

TRUSTED PARTNER


USEFUL LINKS

  • EUROGIN PORTAL |
  • Previous events |
  • Legal Information |
  • Cancellation Policy |
  • Delegates Terms & Conditions |
  • Refund Request Process

ENDORSED BY / PARTNERSHIPS

Informa Markets

Copyright © 2020. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions